News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rangwala Reshma
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 05/02/2022 |
4
| Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 65,000 shares
@ $0
Granted 100,000 options to buy
@ $6.1, valued at
$610k
|
|
| 04/29/2022 |
3
| Rangwala Reshma (EVP & Chief Medical Officer) has filed a Form 3 on Karyopharm Therapeutics Inc. |
| 01/25/2022 |
4
| Rangwala Reshma (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.18, valued at
$381.5k
|
|
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2020 |
4
| Rangwala Reshma (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 75,000 options
@ $4.95, valued at
$371.3k
|
|
| 09/29/2020 |
3
| Rangwala Reshma (Chief Medical Officer) has filed a Form 3 on Aravive, Inc. |
|
|